Biotech Stocks

Short Seller Report Is Just a Distraction from Aphria (APHA) National Success, Says Analyst

If buying marijuana legally doesn’t already seem a bit scandalous, then surely the cunning short report about Canadian cannabis company Aphria (APHA) will …

Proteostasis Therapeutics (PTI) Sparks Optimism Among Investors; Here’s Why

Proteostasis Therapeutics (PTI) announced today a worldwide, exclusive license agreement with Genentech for the rights to a potential new therapy, without revealing what …

Should You Buy Into the Johnson & Johnson (JNJ) Stock Weakness? Analysts Say Yes

It was a short and dramatic plunge for Johnson & Johnson (JNJ). The stock lost over 10% of its value following a Reuters report …

Top Analyst Says New Age Beverages (NBEV) Takeover is Doorway to Global Expansion, Bullish on the Stock

New Age Beverages Corporation (NBEV) announced earlier this month the acquisition of Morinda Holdings for $85 million. Since the takeover, the company’s shares …

Analyst Backs Aphria (APHA) Stock Through Rough Patch, But Lowers Price Target

Aphria (APHA) is trying to recover from a near $1.1 billion loss in value after a harsh short report came out suggesting the …

Catalyst Pharmaceuticals (CPRX) Stock Receives Upbeat Wall Street Comments

Catalyst Pharmaceuticals (CPRX) hosted a conference call yesterday to discuss its commercialization plan for the company’s newly FDA-approved LEMS drug, Firdapse. Catalyst announced …

Bausch Health (BHC) Stock: Steadfast Bear Raises a New Alarm

Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.

Is There Any Hope for Neurocine Biosciences (NBIX) Stock? Cowen Weighs In

Neurocine Biosciences (NBIX) stock dropped about 14% Wednesday after news that its clinical trial for Ingrezza T-Force GOLD, for the treatment of Tourrette …

Aphria (APHA) Analyst Drops Bomb on Stock After Short Report Scandal

Following an intense short report alleging Aphria (APHA), a Canadian cannabis company, is scamming its investors, analysts are having second guesses about the …

Bausch Health (BHC) (Tries) to Save Synergy Pharmaceuticals (SGYP) While It’s Down; Analyst Sees Upside for the Stock

Bausch Health Companies (BHC) announced today it will acquire some assets of Synergy Pharmaceuticals, which is being called the “stalking horse” agreement – …